HSBC Holdings
CTMX icon

HSBC Holdings’s CytomX Therapeutics CTMX Stock Holding History

HSBC Holdings’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,230
Closed -$52.1K – 2967
2025
Q4 		$52.1K Buy
+12,230
New +$46.5K ﹤0.01% 2863
2021
Q1 		– Sell
-15,890
Closed -$105K – 2797
2020
Q4 		$105K Buy
15,890
+3,954
+33% +$28.2K ﹤0.01% 2944
2020
Q3 		$80K Sell
11,936
-1,899
-14% -$14.1K ﹤0.01% 2648
2020
Q2 		$115K Sell
13,835
-683
-5% -$6.34K ﹤0.01% 2498
2020
Q1 		$111K Buy
14,518
+2,582
+22% +$18K ﹤0.01% 2455
2019
Q4 		$99K Sell
11,936
-1,596
-12% -$10.8K ﹤0.01% 2929
2019
Q3 		$100K Buy
+13,532
New +$133K ﹤0.01% 2977
2018
Q3 		– Sell
-9,718
Closed -$222K – 2556
2018
Q2 		$222K Buy
+9,718
New +$248K ﹤0.01% 2404

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return